Skip to main content

Table 3 The associations of underlying diseases type and patient ages when they received infusion with the incidence of haAEs and total deaths, respectively

From: Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study

 

haAEs (cases%)

Total deaths (cases%)

Diseases

 SLE

18 (10.11%)

14 (7.87%)

 PM/DM

6 (20%)

11 (36.67%)

 SS

9 (12.50%)

8 (11.11%)

 SSc

7 (17.95%)

6 (15.38%)

 RA

3 (9.28%)

3 (9.38%)

 others

5 (9.43%)

3 (5.66%)

 p value

> 0.1

< 0.05

Ages

 ≤ 20 year

5 (11.63%)

4 (9.30%)

 20–40 year

18 (10.06%)

9 (5.03%)

 > 40 year

25 (13.74%)

32 (17.58%)

 p value

> 0.1

< 0.05

  1. SLE systemic lupus erythematosus, PM/DM polymyositis/dermatomyositis, SS Sjögren’s syndrome, SSc systemic sclerosis, RA rheumatoid arthritis